Biotechnology News REGRANEX Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-8 out of 8 found

Current Search: regranex: 8

J&J to divest Professional Wound Care business
Ethicon conducted a competitive bidding process to prepare for the divestiture of the Professional Wound Care business, and as a result of such process and receipt of the offer, has decided to grant exclusivity to One Equity Partners.

Pharmaceutical Business Review: Jul 4 2008 9:35PM
Matching: regranex

Find similar documents

Regranex Foot Gel Gets Stiffer Warnings
The warning reads: 'An increased risk of mortality secondary to malignancy was observed in patients treated with three or more tubes of Regranex gel in a post-marketing retrospective cohort study.

Regranex gel should only be...

Pharmaceutical Executive: Jun 11 2008 5:31AM
Matching: regranex

Find similar documents

Ethicon announces revised labelling for Regranex Gel
Ethicon, Inc.

announces revised labeling for Regranex Gel, a topical formulation of recombinant human platelet-derived growth factor indicated as an adjunct to the treatment of lower extremity diabetic neuropathic ulcers.

The...

PharmaBiz: Jun 10 2008 10:20AM
Matching: regranex

Find similar documents

Ethicon Announces Revised Label For Regranex (becaplermin) Gel 0.01%
/PRNewswire/ -- ETHICON, INC.

today announces revised labeling for REGRANEX Gel, a topical formulation of recombinant human platelet-derived growth factor indicated as an adjunct to the treatment of lower extremity diabetic...

Pharma Live: Jun 6 2008 6:41PM
Matching: regranex

Find similar documents

FDA Announces New Labeling Changes for Regranex
The U.S.

Food and Drug Administration today announced the addition of a boxed warning to the label of Regranex Gel 0.01% (becaplermin) to address the increased risk of cancer mortality in patients who use 3 or more tubes of the...

Pharma Live: Jun 6 2008 9:03PM
Matching: regranex

Find similar documents

FDA adds cancer warnings to J&J foot ulcer cream
WASHINGTON The Food and Drug Administration warned patients Friday that using large amounts of a Johnson & Johnson foot ulcer medication could heighten their risk of dying from cancer.

The FDA added its most serious warning to the...

SignOn San Diego: Jun 6 2008 8:05PM
Matching: regranex

Find similar documents

FDA adds cancer warnings to J&J foot ulcer cream
WASHINGTON (AP) - The Food and Drug Administration warned patients Friday that using large amounts of a Johnson & Johnson foot ulcer medication could heighten their risk of dying from cancer.

The FDA added its most serious warning to...

Sharewatch: Jun 6 2008 7:10PM
Matching: regranex

Find similar documents

FDA adds cancer warnings to J&J foot ulcer cream
The Food and Drug Administration warned patients Friday that using large amounts of a Johnson & Johnson foot ulcer medication could heighten their risk of dying from cancer.

The FDA added its most serious warning to the company's cream...

San Francisco Chronicle: Jun 6 2008 9:39PM
Matching: regranex

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.